Clinical Trial: Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous Formulation
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Multiple Sclerosis
Study Type: OBSERVATIONAL
Official Title: Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous Formulation (MS-PEKOS)
Brief Summary:
The study aims to compare the experiences, including injection-related reactions (IRRs) of patients newly receiving ofatumumab to those starting to receive ocrelizumab SC formulation
Read more